Daniel H. PetreeChairman    Mr. Petree has over 30 years of experience in the biotechnology industry, serving in a variety of roles including investment banker, senior operating manager and corporate and securities lawyer. Mr. Petree is a member and co-founder of P2 Partners, LLC (founded in 2000) and Four Oaks Partners (founded in 2012), both of which provide transaction advisory services to small and medium sized life science companies. Before co-founding P2 Partners in 2000, Mr. Petree was President and Chief Operatiing Officer of Axys Pharmaceuticals, a publicly held, structure-based drug design company in South San Francisco. Currently, Mr. Petree serves as a director of Sutro Biopharma, Inc., a South San Francisco, CA - based, privately held biotechnology company and NKT Therapeutics Inc., a Waltham, MA - based, privately held biotechnology company.     ​

Board of Directors 



Donald Swortwood - ​Managing Partner